Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
December 1, 1980
[Hyperlipoproteinemia type II]
R W Schade
The New England Journal of Medicine
|
September 22, 1977
Clofibrate effect on alkaline phosphatase: bone or liver fraction
R W Schade, P N Demacker, A van't Laar
The Netherlands Journal of Medicine
|
January 1, 1973
Treatment of type II hyperlipoproteinaemia with cholestyramine
R W Schade, Laar A van't, A P Jansen
Lancet (London, England)
|
April 12, 1975
Letter: Reduction of serum-alkaline-phosphatase by clofibrate
R W Schade, P N Demacker, A van T Laar
The Netherlands Journal of Medicine
|
March 1, 1995
Palliative chemotherapy with CMF after the same adjuvant regimen for breast cancer. The Breast Cancer Study Group
M Gerritsen, D J Wagener, R W Schade, et al.
Acta Medica Scandinavica
|
January 1, 1976
A comparative study of the effects of cholestyramine and neomycin in the treatment of type II hyperlipoproteinaemia
R W Schade, A van't Laar, C L Majoor, et al.
Lancet (London, England)
|
July 1, 1978
H.D.L. cholesterol during oral contraception
R W Schade, J P Meuwese, A J Thoben, et al.
Atherosclerosis
|
December 1, 1982
Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans
P N Demacker, R W Schade, R T Jansen, et al.
British Medical Journal (Clinical Research Ed.)
|
April 24, 1982
Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations
P N Demacker, R W Schade, A F Stalenhoef, et al.
The American Journal of Clinical Nutrition
|
April 1, 1979
Effect of a standardized wheat bran preparation on serum lipids in young healthy males
G P van Berge-Henegouwen, A W Huybregts, S van de Werf, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Nederlands Tijdschrift Voor Geneeskunde
|
December 1, 1980
[Hyperlipoproteinemia type II]
R W Schade
The New England Journal of Medicine
|
September 22, 1977
Clofibrate effect on alkaline phosphatase: bone or liver fraction
R W Schade, P N Demacker, A van't Laar
The Netherlands Journal of Medicine
|
January 1, 1973
Treatment of type II hyperlipoproteinaemia with cholestyramine
R W Schade, Laar A van't, A P Jansen
Lancet (London, England)
|
April 12, 1975
Letter: Reduction of serum-alkaline-phosphatase by clofibrate
R W Schade, P N Demacker, A van T Laar
The Netherlands Journal of Medicine
|
March 1, 1995
Palliative chemotherapy with CMF after the same adjuvant regimen for breast cancer. The Breast Cancer Study Group
M Gerritsen, D J Wagener, R W Schade, et al.
Acta Medica Scandinavica
|
January 1, 1976
A comparative study of the effects of cholestyramine and neomycin in the treatment of type II hyperlipoproteinaemia
R W Schade, A van't Laar, C L Majoor, et al.
Lancet (London, England)
|
July 1, 1978
H.D.L. cholesterol during oral contraception
R W Schade, J P Meuwese, A J Thoben, et al.
Atherosclerosis
|
December 1, 1982
Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans
P N Demacker, R W Schade, R T Jansen, et al.
British Medical Journal (Clinical Research Ed.)
|
April 24, 1982
Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations
P N Demacker, R W Schade, A F Stalenhoef, et al.
The American Journal of Clinical Nutrition
|
April 1, 1979
Effect of a standardized wheat bran preparation on serum lipids in young healthy males
G P van Berge-Henegouwen, A W Huybregts, S van de Werf, et al.
Page
of 2